⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KRRO News
Korro Bio, Inc. Common Stock
Form 8-K
sec.gov
KRRO
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
globenewswire.com
KRRO
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
KRRO
Form 8-K
sec.gov
KRRO
Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
KRRO
Korro to Participate in Upcoming Investor Conferences
globenewswire.com
KRRO
Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences
globenewswire.com
KRRO
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
KRRO
Form 8-K
sec.gov
KRRO
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
KRRO